Our short-term analysis of cellular parameters revealed that octyl-D-2-HG treatment exerted comparable effects on cell proliferation, ROS, apoptosis, and cell death levels of NCI-H460 cancer cells, suggesting that this oncometabolite is responsible for the respective short effects observed upon SLC25A1-inhibition by CTPI2. Here, SLC25A1 is linked to cancer.